Search research articles
Contact Us
Filters
Showing results (51-60 of 79) with videos related to
Page
of 8
Sort By:
Frontiers in Oncology
|
March 17, 2022
<i>DNMT3A</i> R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation
Majd Jawad, Michelle Afkhami, Yi Ding, et al.
American Journal of Clinical Pathology
|
November 17, 2021
Bone Marrow Collection: Comparison of Unassisted vs Assisted Bedside Collections by a Laboratory Technologist
Saba F Ali, Adam Cloe, Parwiz J Siaghani, et al.
Plos One
|
November 7, 2019
Mutation and immune profiling of metaplastic breast cancer: Correlation with survival
Michelle Afkhami, Daniel Schmolze, Susan E Yost, et al.
The American Journal of Surgical Pathology
|
February 11, 2025
Clinicopathologic and Molecular Characterization of Gynecologic Carcinosarcomas With a Mesonephric-Like Carcinomatous Component
Rachelle P Mendoza, Melisa Y Tjota, Donghyuk N Choi, et al.
International Journal of Molecular Sciences
|
January 25, 2025
Application of RNA-Based Next-Generation Sequencing Fusion Assay for Hematological Malignancies
Fei Fei, Milhan Telatar, Vanina Tomasian, et al.
Translational Lung Cancer Research
|
June 15, 2026
Patterns of central nervous system disease and molecular landscape in epidermal growth factor receptor exon 20 insertion mutated non-small cell carcinoma
Amanda Reyes, Isa Mambetsariev, Jeremy Fricke, et al.
Cancers
|
October 14, 2022
Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
Dan Zhao, Haiqing Li, Isa Mambetsariev, et al.
American Journal of Hematology
|
February 8, 2022
High prevalence and inferior long-term outcomes for TP53 mutations in therapy-related acute lymphoblastic leukemia
Hoda Pourhassan, Dongyun Yang, Michelle Afkhami, et al.
NPJ Precision Oncology
|
June 19, 2024
Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome
Dan Zhao, Haiqing Li, Isa Mambetsariev, et al.
Journal for Immunotherapy of Cancer
|
July 29, 2024
Exploring markers of immunoresponsiveness in papillary thyroid carcinoma and future treatment strategies
Atish Mohanty, Michelle Afkhami, Amanda Reyes, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 79) with videos related to
Sort By:
Page
of 8
Frontiers in Oncology
|
March 17, 2022
<i>DNMT3A</i> R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation
Majd Jawad, Michelle Afkhami, Yi Ding, et al.
American Journal of Clinical Pathology
|
November 17, 2021
Bone Marrow Collection: Comparison of Unassisted vs Assisted Bedside Collections by a Laboratory Technologist
Saba F Ali, Adam Cloe, Parwiz J Siaghani, et al.
Plos One
|
November 7, 2019
Mutation and immune profiling of metaplastic breast cancer: Correlation with survival
Michelle Afkhami, Daniel Schmolze, Susan E Yost, et al.
The American Journal of Surgical Pathology
|
February 11, 2025
Clinicopathologic and Molecular Characterization of Gynecologic Carcinosarcomas With a Mesonephric-Like Carcinomatous Component
Rachelle P Mendoza, Melisa Y Tjota, Donghyuk N Choi, et al.
International Journal of Molecular Sciences
|
January 25, 2025
Application of RNA-Based Next-Generation Sequencing Fusion Assay for Hematological Malignancies
Fei Fei, Milhan Telatar, Vanina Tomasian, et al.
Translational Lung Cancer Research
|
June 15, 2026
Patterns of central nervous system disease and molecular landscape in epidermal growth factor receptor exon 20 insertion mutated non-small cell carcinoma
Amanda Reyes, Isa Mambetsariev, Jeremy Fricke, et al.
Cancers
|
October 14, 2022
Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
Dan Zhao, Haiqing Li, Isa Mambetsariev, et al.
American Journal of Hematology
|
February 8, 2022
High prevalence and inferior long-term outcomes for TP53 mutations in therapy-related acute lymphoblastic leukemia
Hoda Pourhassan, Dongyun Yang, Michelle Afkhami, et al.
NPJ Precision Oncology
|
June 19, 2024
Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome
Dan Zhao, Haiqing Li, Isa Mambetsariev, et al.
Journal for Immunotherapy of Cancer
|
July 29, 2024
Exploring markers of immunoresponsiveness in papillary thyroid carcinoma and future treatment strategies
Atish Mohanty, Michelle Afkhami, Amanda Reyes, et al.
Page
of 8